secwatch.observer — SEC 8-K summary
======================================

Issuer:     DarioHealth Corp. (DRIO)
CIK:        0001533998
Form:       8-K
Filed at:   2024-12-18T23:59:59+00:00
Accession:  0001104659-24-129777
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DarioHealth raises ~$18.8M via preferred stock; amends Avenue loan to extend maturity
--------------------------------------------------------------------------------

- Closed private placement of 7,055 Series D and 11,750 Series D-1 preferred shares at $1,000 each, raising $18.8M.
- Preferred stock convertible at $0.73/share, subject to stockholder approval and a 19.99% beneficial ownership blocker.
- Amended Avenue loan: extended interest-only period by 6 months, conditional on revenue milestone; maturity extended to Nov 1, 2027.
- Proforma cash balance of $34M as of Q3 2024; company targets profitability run-rate by end of 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533998/000110465924129777/0001104659-24-129777-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533998/000110465924129777/tm2431382d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-129777

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer